Description:

CALGB: 90202 OFF TREATMENT NOTICE Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B460546D-46F1-0505-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B460546D-46F1-0505-E034-0003BA12F5E7

Keywords:
Versions (3) ▾
  1. 4/19/12
  2. 1/9/15
  3. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Prostate Cancer NCT00079001 Off Treatment - CALGB 90202 OFF TREATMENT NOTICE 2075955_v3_0

No Instruction available.

  1. StudyEvent: CALGB: 90202 OFF TREATMENT NOTICE
    1. No Instruction available.
Ccrr Module For Calgb: 90202 Off Treatment Notice